Search research articles
Contact Us
Filters
Showing results (71-80 of 148) with videos related to
Page
of 15
Sort By:
Blood Advances
|
April 25, 2022
Npm1 haploinsufficiency in collaboration with MEIS1 is sufficient to induce AML in mice
Andrew Muranyi, Tobias Ammer, Anna Kechter, et al.
Discover Oncology
|
February 14, 2025
Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia
Ya Hwee Tan, Dok Hyun Yoon, Andrew J Davies, et al.
Genes, Chromosomes & Cancer
|
April 19, 2011
Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20
Tobias Herold, Vindi Jurinovic, Medhanie Mulaw, et al.
The Lancet. Haematology
|
July 1, 2018
Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review
Christian Buske, Shalal Sadullah, Efstathios Kastritis, et al.
International Journal of Cancer
|
April 28, 2015
Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens
Vanessa Schneider, Lu Zhang, Markus Rojewski, et al.
The Journal of Experimental Medicine
|
March 5, 2008
A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis
Konstantin Petropoulos, Natalia Arseni, Christina Schessl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes
Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos, et al.
Leukemia & Lymphoma
|
November 30, 2012
High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature
Tobias Herold, Medhanie A Mulaw, Vindi Jurinovic, et al.
Leukemia & Lymphoma
|
January 20, 2022
A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia
Panayiotis Panayiotidis, Gayane Tumyan, Catherine Thieblemont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia
Arati V Rao, Peter J M Valk, Klaus H Metzeler, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 148) with videos related to
Sort By:
Page
of 15
Blood Advances
|
April 25, 2022
Npm1 haploinsufficiency in collaboration with MEIS1 is sufficient to induce AML in mice
Andrew Muranyi, Tobias Ammer, Anna Kechter, et al.
Discover Oncology
|
February 14, 2025
Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia
Ya Hwee Tan, Dok Hyun Yoon, Andrew J Davies, et al.
Genes, Chromosomes & Cancer
|
April 19, 2011
Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20
Tobias Herold, Vindi Jurinovic, Medhanie Mulaw, et al.
The Lancet. Haematology
|
July 1, 2018
Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review
Christian Buske, Shalal Sadullah, Efstathios Kastritis, et al.
International Journal of Cancer
|
April 28, 2015
Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens
Vanessa Schneider, Lu Zhang, Markus Rojewski, et al.
The Journal of Experimental Medicine
|
March 5, 2008
A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis
Konstantin Petropoulos, Natalia Arseni, Christina Schessl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes
Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos, et al.
Leukemia & Lymphoma
|
November 30, 2012
High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature
Tobias Herold, Medhanie A Mulaw, Vindi Jurinovic, et al.
Leukemia & Lymphoma
|
January 20, 2022
A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia
Panayiotis Panayiotidis, Gayane Tumyan, Catherine Thieblemont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia
Arati V Rao, Peter J M Valk, Klaus H Metzeler, et al.
Page
of 15